cas 1206989-81-2|| where to buy N-(2-cyclopropanecarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-5-phenyl-1,2-oxazole-3-carboxamide

Nombre del producto:N-(2-cyclopropanecarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-5-phenyl-1,2-oxazole-3-carboxamide

IUPAC Name:N-(2-cyclopropanecarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-5-phenyl-1,2-oxazole-3-carboxamide

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1206989-81-2 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1206989-81-2; Fórmula molecular:C23H21N3O3; Punto de fusión:-; Código de sonrisas:O=C(NC1=CC2=C(CCN(C2)C(=O)C2CC2)C=C1)C1=NOC(=C1)C1=CC=CC=C1; Densidad:

: Número de catálogo:CM940089; Peso molecular:387.44; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Isoxazoles; Isoxazole is a liquid heterocyclic compound C3H3NO isomeric with oxazole and having a penetrating odor like that of pyridine. Isoxazoles belong to an important class of five-membered aromatic heterocycles containing two electronegative heteroatoms, nitrogen and oxygen, in a 1,2-relationship and three regular sp2 carbon atoms. These molecules are found to be key components in various synthetic products in daily use and also present as a pharmacophore essential for biological activity in many drugs and bioactive natural products. In addition, isoxazoles have demonstrated their ability to exhibit hydrogen bond donor/acceptor interactions with a variety of enzymes and receptors.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.